Stryker (SYK) Free Cash Flow Growth (3y) (2012 - 2026)
Stryker (SYK) Free Cash Flow Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | 41.96% |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 25.48% |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | 0.05% |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 35.42% |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 250.09% |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | 12.01% |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | 35.65% |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | 20.87% |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 9.23% |
| 10 | Zimmer Biomet Holdings | 19.36 Bn | 18.95 Bn | 1.54 Bn | 16.24% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 25.48% |
| Mar 31, 2026 | 9.63% |
| Dec 31, 2025 | 32.01% |
| Sep 30, 2025 | 21.68% |
| Jun 30, 2025 | 33.96% |
| Mar 31, 2025 | 14.77% |
| Dec 31, 2024 | 28.00% |
| Sep 30, 2024 | 17.54% |
| Jun 30, 2024 | -14.59% |
| Mar 31, 2024 | -53.54% |
| Dec 31, 2023 | 8.86% |
| Sep 30, 2023 | 5.88% |
| Jun 30, 2023 | 1.60% |
| Mar 31, 2023 | -11.01% |
| Dec 31, 2022 | 14.99% |
| Sep 30, 2022 | 17.24% |
| Jun 30, 2022 | 3.42% |
| Mar 31, 2022 | -23.95% |
| Dec 31, 2021 | -3.81% |
| Sep 30, 2021 | 18.88% |